Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) FCF Margin (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 6 years of FCF Margin data on record, last reported at 30.17% in Q3 2025.

  • For Q3 2025, FCF Margin rose 85436.0% year-over-year to 30.17%; the TTM value through Sep 2025 reached 48.16%, up 316524.0%, while the annual FY2024 figure was 216.65%, N/A changed from the prior year.
  • FCF Margin reached 30.17% in Q3 2025 per CYCN's latest filing, up from 540.86% in the prior quarter.
  • Across five years, FCF Margin topped out at 1377.08% in Q3 2022 and bottomed at 23314.52% in Q1 2021.
  • Average FCF Margin over 4 years is 2832.89%, with a median of 1039.8% recorded in 2024.
  • Peak YoY movement for FCF Margin: tumbled -2043296bps in 2021, then surged 2150931bps in 2022.
  • A 4-year view of FCF Margin shows it stood at 1619.14% in 2021, then skyrocketed by 185bps to 1377.08% in 2022, then tumbled by -99bps to 19.93% in 2024, then crashed by -251bps to 30.17% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 30.17% in Q3 2025, 540.86% in Q2 2025, and 1195.06% in Q1 2025.